Register entry

SQ Innovation, Inc

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
3
Countries
1
Base
United States
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
SQ Innovation, Inc20 Burlington Mall Road Suite 220, Burlington, Massachusetts (MA) 01803, United States (USA)Finished drug manufacture3015904951117146655
Exclusivity

Patents and exclusivities

3
PatentProductCoversExpiry
11246851LASIX ONYUfurosemideproductJan 2040
12318363LASIX ONYUfurosemideproductJan 2040
12403120LASIX ONYUfurosemideproductJan 2042
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
LASIX ONYUfurosemideinjection, subcutaneous81137-001NDA
Neighbours

Registered in the same town

1
Compare

Comparable companies in United States

Enquiry

Common questions

Is SQ Innovation, Inc FDA approved?
SQ Innovation, Inc holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are SQ Innovation, Inc's drugs manufactured?
The FDA register lists Burlington, MA. Registered operations: finished drug manufacture.
What drugs does SQ Innovation, Inc make?
1 product is listed under SQ Innovation, Inc in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.